Skip to main content
Clinical Trials/NCT06238999
NCT06238999Active, not recruitingNot Applicable

Clinical Evaluation of a New Flowable Composite for Direct Restorative Treatment of Non-carious Cervical Lesions: A Prospective Randomized Split-mouth Study

Ivoclar Vivadent AG2 sites in 1 country66 target enrollmentStarted: February 20, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
66
Locations
2
Primary Endpoint
Postoperative Hypersensitivity

Study Overview

Brief Summary

The overall objective of this clinical investigation is to evaluate the clinical safety and performance of the new flowable composite TM Flow for treatment of non-carious cervical lesions. Each participant receives two different fillings (test- and control material) in two different teeth. The fillings are assessed according to selected FDI criteria at baseline (7-10 days after filling placement) and after 1, 6, 12, 24, 36 and 60 months.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Informed Consent signed by the subject
  • •Age: 18-65 years
  • •2 NCCL needing treatment, comparable in extend and size, preferably located in different quadrants
  • •Vital teeth, regular sensitivity
  • •Sufficient language skills
  • •No active periodontitis
  • •Preoperative VAS values < 3 regarding tooth sensitivity on biting. Tooth sensitivity on temperature or touching (tooth brushing, probing) originating in the area of the NCCL is accepted.
  • •Subject wishes to have a restoration as part of the study (written declaration of consent after detailed explanation)

Exclusion Criteria

  • •Not completed hygiene phase or poor oral hygiene
  • •Sufficient isolation of the cavity not possible
  • •Patients with a proven allergy to one of the ingredients (methacrylates)
  • •Patients with severe systemic diseases
  • •Periodontally insufficient dentition
  • •Pregnancy
  • •Part of the development project team of TM Flow
  • •Staff of the study management team
  • •Staff of the internal clinic

Arms & Interventions

Test goup TM Flow

Experimental

The newly developed flowable composite TM Flow will be used for the restoration of NCCLs in the test group. The treatment workflow is very similar to other flowable composites.

Intervention: Restoration of non-carious cervical lesions (Device)

Control group Tetric EvoFlow

Active Comparator

The well-established Tetric EvoFlow will be used for the restorations of NCCLs in the control group.

Intervention: Restoration of non-carious cervical lesions (Device)

Outcomes

Primary Outcomes

Postoperative Hypersensitivity

Time Frame: 1 month

assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable" FDI 1: no complaint FDI 2: minor complaint FDI 3: distinct pain FDI 4: persistent pain for prolonged period of time FDI 5: treatment unavoidable

Postoperative Hypersensitivity

Time Frame: 1 month

assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable" FDI 1: no complaint FDI 2: minor complaint FDI 3: distinct pain FDI 4: persistent pain for prolonged period of time FDI 5: treatment unavoidable

Secondary Outcomes

  • Evaluation of Functional (e.g. Fracture of the Material and Retention), Biological (e.g. Caries at Restoration Margins) and Aesthetic (e.g. Color Match) Properties of the Restorations(5 years)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials